Anaplastic large cell lymphoma pediatric · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG ANHL12P1 protocol N/A - intrathecal component | — | R 94 763 | 21d | — | — | — | — | — |
EICNHL ALCL99 protocol N/A - intrathecal component | — | R 9 519 | 21d | — | — | — | — | — |
APO Variant #01 | — | R 2 553 | 42d | — | — | — | — | — |
3 of 3 regimens shown